Department of Nuclear Science and Technology, Nanjing University of Aeronautics and Astronautics, Nanjing, 211106, P.R. China , zhangxiaohong@nuaa.edu.cn
Abstract: (596 Views)
Background:Radiosensitizers enhance the effectiveness of radiation therapy by reducing the radio-resistance of cancer cells. A key advantage of traditional drug repositioning over the development of new drugs is the rapid repurposing of existing medications for new therapeutic applications. Mefloquine, a classical antimalaria drug, has also demonstrated anti-tumor activity through various mechanisms. The goal of this study is to investigate the potential of mefloquine as a radiosensitizer on gliomas. Materials and Methods: Gliomas were pre-treated with mefloquine prior to X-ray irradiation. The radiosensitization of mefloquine on these cells was first estimated using a clonogenic formation assay. To determine the mode of cell death, apoptosis and autophagy were measured in U251 gliomas at different intervals after mefloquine-mediated radiosensitization. Additionally, intracellular levels of reactive oxygen species and calcium ions were measured to explore the molecular mechanism during mefloquine-mediated radiosensitization. Results: Mefloquine was demonstrated to present a notable radiosensitizing effect on gliomas. However, the enhancement of protective autophagy diminished the radiosensitizing effect on the first day following combined treatment with mefloquine and X-rays. From the third day onward, the radiosensitization became more pronounced, attributed to a reduction in protective autophagy and an increase in apoptosis. Further study revealed that the increased apoptosis during mefloquine-mediated radiosensitization was dependent on intracellular reactive oxygen species levels, as the apoptotic response was inhibited by glutathione. Conclusion: Our findings demonstrate that mefloquine can elevate the radiosensitivity of gliomas through reactive oxygen species-dependent apoptosis.
1. 1. Lah TT, Novak M, Breznik B (2020) Brain malignancies: glioblastoma and brain metastases. Semin Cancer Biol, 60: 262-273. [DOI:10.1016/j.semcancer.2019.10.010]
2. Ebrahimi A, Khoramian D, Tabatabaei N, Sarvizadeh S (2024) Temozolomide overdose in treating high-grade glioma: A case report. Int J Radiat Res, 22: 807-809. [DOI:10.61186/ijrr.22.3.807]
3. Poon MT, Sudlow C, Figueroa JD, Brennan PM (2020) Longer-term (≥ 2 years) survival in patients with glioblastoma in population-based studies pre- and post-2005: A systematic review and meta-analysis. Sci Rep, 10: 11622. [DOI:10.1038/s41598-020-68011-4]
4. Berber T, Harmankaya I, Aksaray F, Buyukpolat Y, Adatepe F, Yilmaz BD, et al. (2022) Extreme hypofractionated radiosurgery in recurrent inoperable high-grade ultra-large gliomas. Int J Radiat Res, 20: 643-648.
5. Chen L, Ma J, Zou Z, Liu HZ, Liu C, Gong S, et al. (2022) Clinical characteristics and prognosis of patients with glioblastoma: A review of survival analysis of 1674 patients based on SEER database. Medicine (Baltimore), 101: e32042. [DOI:10.1097/MD.0000000000032042]
6. Burko P, D'Amico G, Miltykh I, Scalia F, de Macario EC, Macario A, Giglia G, et al. (2023) Molecular pathways implicated in radioresistance of glioblastoma multiforme: What is the role of extracellular vesicles? Int J Mol Sci, 24: 4883. [DOI:10.3390/ijms24054883]
7. Jiao YF, Cao FY, Liu H (2022) Radiation-induced cell death and its mechanisms. Health Phys, 123: 376-386. [DOI:10.1097/HP.0000000000001601]
8. Zhang BB, Zhang MY, Tian JL, Zhang X, Zhang D, Li JB, Yang L (2024) Advances in the regulation of radiation-induced apoptosis by polysaccharides: A review. Int J Biol Macromol, 263: 130173. [DOI:10.1016/j.ijbiomac.2024.130173]
9. Suzuki M, Anko M, Ohara M, Matsumoto K, Hasegawa S (2021) Radiation-induced autophagy in human pancreatic cancer cells is critically dependent on G2 checkpoint activation: A mechanism of radioresistance in pancreatic cancer. Int J Radiat Oncol Biol Phys, 111: 260-271. [DOI:10.1016/j.ijrobp.2021.04.001]
10. Zhu W, Zhang XF, Yu ML, Lin B R, Yu CH (2021) Radiation-induced liver injury and hepatocyte senescence. Cell Death Discov, 7: 224. [DOI:10.1038/s41420-021-00634-6]
11. Zhang Z, Yang J, Maimaitiyimin R, Ma M, Zhang H, Wang R (2020) Radiation-induced mitotic catastrophe is associated with down-regulated ribosomal biosynthesis and mitosis genes. All Life, 13: 474-485. [DOI:10.1080/26895293.2020.1806117]
12. Zhang X, Xing X, Liu H, Feng J, Tian M, Chang S, et al. (2020) Ionizing radiation induces ferroptosis in granulocyte-macrophage hematopoietic progenitor cells of murine bone marrow. Int J Radiat Biol, 96: 584-595. [DOI:10.1080/09553002.2020.1708993]
13. Berry C, Kendig CB, An N, Fazilat A, Churukian AA, Griffin M, et al. (2024) Role of ferroptosis in radiation-induced soft tissue injury. Cell Death Discov, 10: 313. [DOI:10.1038/s41420-024-02003-5]
14. Boon N, Oliveira R, Korner P, Kochavi A, Mertens S, Malka Y, et al. (2024) DNA damage induces P53-independent apoptosis through ribosome stalling. Science, 384: 785-792. [DOI:10.1126/science.adh7950]
15. Kondo T (2013) Radiation-induced cell death and its mechanisms. Radiat Emergency Med, 2: 1-4.
16. Biswas U, Roy R, Ghosh S, Chakrabarti G (2024) The interplay between autophagy and apoptosis: Its implication in lung cancer and therapeutics. Cancer Lett, 585: 216662. [DOI:10.1016/j.canlet.2024.216662]
17. Zheng ZZ, Su J, Bao XY, Wang H, Bian CB, et al. (2023) Mechanisms and applications of radiation-induced oxidative stress in regulating cancer immunotherapy. Front Immunol, 14: 1247268. [DOI:10.3389/fimmu.2023.1247268]
18. Redza-Dutordoir M, Averill-Bates DA (2016) Activation of apoptosis signalling pathways by reactive oxygen species. BBA-Mol Cell Res, 1863: 2977-2992. [DOI:10.1016/j.bbamcr.2016.09.012]
19. Takahashi K, Inanami O, Kuwabara M (1999) Effects of intracellular calcium chelator BAPTA-AM on radiation-induced apoptosis regulated by activation of SAPK/JNK and caspase-3 in MOLT-4 cells. Int J Radiat Biol, 75: 1099-1105. [DOI:10.1080/095530099139566]
20. Moon DO (2023) Calcium'role in orchestrating cancer apoptosis: Mitochondrial-centric perspective. Int J Mol Sci, 24: 8982. [DOI:10.3390/ijms24108982]
21. Price RN, Uhlemann AC, Brockman A, McGready R, Ashley E, Phaipun L, et al. (2004) Mefloquine resistance in plasmodium falciparum and increased pfmdr1 gene copy number. Lancet, 364: 438-447. [DOI:10.1016/S0140-6736(04)16767-6]
22. Mudassar F, Shen H, O'Neill G, Hau E (2020) Targeting tumor hypoxia and mitochondrial metabolism with anti-parasitic drugs to improve radiation response in high-grade gliomas. J Exp Clin Cancer Res, 39: 208. [DOI:10.1186/s13046-020-01724-6]
23. Li H, Jiao S, Li X, Banu H, Hamal S, Wang X (2017) Therapeutic effects of antibiotic drug mefloquine against cervical cancer through impairing mitochondrial function and inhibiting mTOR pathway. Can J Physiol Pharmacol, 95: 43-50. [DOI:10.1139/cjpp-2016-0124]
24. Wan B, Wu ZH, Zhang XL, Huang BR (2021) Mefloquine as a dual inhibitor of glioblastoma angiogenesis and glioblastoma via disrupting lysosomal function. Biochem Biophys Res Commun, 580: 7-13. [DOI:10.1016/j.bbrc.2021.09.069]
25. Sharma N, Thomas S, Golden EB, Hofman FM, Chen TC, Petasis NA, et al. (2012) Inhibition of autophagy and induction of breast cancer cell death by mefloquine, an antimalarial agent. Cancer Lett, 326:143-154. [DOI:10.1016/j.canlet.2012.07.029]
26. Shin JH, Park SJ, Jo YK, Kim ES, Kang H, Park JH, et al. (2012) Suppression of autophagy exacerbates mefloquine-mediated cell death. Neurosci Lett, 515: 162-167. [DOI:10.1016/j.neulet.2012.03.040]
27. Wong W, Bai XC, Sleebs BE, Triglia T, Brown A, Thompson JK, et al. (2017) Mefloquine targets the plasmodium falciparum 80S ribosome to inhibit protein synthesis. Nat Microbiol, 2: 17031. [DOI:10.1038/nmicrobiol.2017.31]
28. Henary E, Casa S, Dost TL, Sloop JC, Henary M (2024) The role of small molecules containing fluorine atoms in medicine and imaging applications. Pharmaceuticals (Basel), 17: 281. [DOI:10.3390/ph17030281]
29. Zhang XH, Zhou Z, Miao YJ, Liu ZJ, Chen F, Hu X, et al. (2019) Radiosensitizing effect of deferoxamine on human glioma cells. Int J Radiat Res, 17: 325-333.
30. Brix N, Samaga D, Belka C, Zitzelsberger H, Lauber K (2021) Analysis of clonogenic growth in-vitro. Nat Protoc, 16: 4963-4991. [DOI:10.1038/s41596-021-00615-0]
31. Zhang XH, Liu ZJ, Lou ZC, Chen F, Chang SQ, Miao YJ, et al. (2018) Radiosensitivity enhancement of Fe3O4@Ag nanoparticles on human glioblastoma cells. Artif Cells Nanomed Biotechnol, 46 (sup1): 975-984. [DOI:10.1080/21691401.2018.1439843]
32. El Sharazly BM, Ahmed A, Elsheikha HM, Carter WG (2024) An in silico and in vitro assessment of the neurotoxicity of mefloquine. Biomedicines, 12: 505. [DOI:10.3390/biomedicines12030505]
33. Zheng W, Chen Q, Liu H, Zeng L, Zhou Y, Liu X, et al. (2023) SDC1-dependent TGM2 determines radiosensitivity in glioblastoma by coordinating EPG5-mediated fusion of autophagosomes with lysosomes. Autophagy, 19: 839-857. [DOI:10.1080/15548627.2022.2105562]
34. Roy A, Bera S, Saso L, Dwarakanath BS (2022) Role of autophagy in tumor response to radiation: implications for improving radiotherapy. Front Oncol, 12: 957373. [DOI:10.3389/fonc.2022.957373]
35. Martins AC, Paoliello MMB, Docea AO, Santamaria A, Tinkov AA, Skalny AV, Aschner M (2021) Review of the mechanism underlying mefloquine-induced meurotoxicity. Crit Rev Toxicol, 51: 209-216. [DOI:10.1080/10408444.2021.1901258]
Wang A, Miao Y, Guo A, Hu X, Ding Z, Zhang X. Mefloquine enhances radiosensitivity of glioma cells through ROS-dependent apoptosis. Int J Radiat Res 2026; 24 (2) :465-471 URL: http://ijrr.com/article-1-7028-en.html